Discovering Undiscovered Gems in Global for April 2026

As global markets show resilience with notable gains in major indices, buoyed by easing geopolitical tensions and a decline in oil prices, investor sentiment has shifted positively. This environment provides a fertile ground for identifying undiscovered gems—stocks that may be undervalued or overlooked but have the potential to thrive amid improving market conditions and renewed optimism.Top 10 Undiscovered Gems With Strong Fundamentals GloballyNameDebt To EquityRevenue GrowthEarnings GrowthHealth RatingJinghua Pharmaceutical GroupNA2.42%18.34%★★★★★★MCH Group113.30%18.83%72.85%★★★★★★Shantou Institute of Ultrasonic InstrumentNA5.53%14.23%★★★★★★Jiangsu Rainbow Heavy Industries25.93%19.62%2.58%★★★★★☆House of Investments18.23%14.46%47.47%★★★★★☆Zhongyeda Electric0.41%-0.88%-14.90%★★★★★☆Hamat Group44.59%3.36%-28.02%★★★★☆☆Xiamen King Long Motor Group124.24%11.47%34.64%★★★★☆☆Wuhan Huakang Century Clean Technology54.19%21.27%6.99%★★★★☆☆Plus Group Holdings12.04%35.49%-38.12%★★★★☆☆ Click here to see the full list of 3136 stocks from our Global Undiscovered Gems With Strong Fundamentals screener. Underneath we present a selection of stocks filtered out by our screen.Hefei I-TEK OptoElectronics (SHSE:688610)Simply Wall St Value Rating: ★★★★★★Overview: Hefei I-TEK OptoElectronics Co., Ltd. is engaged in the design, development, manufacturing, and marketing of industrial imaging, high precision optics, and opto-electrical equipment in China with a market cap of CN¥6.33 billion.Operations: I-TEK OptoElectronics generates revenue primarily from industrial imaging, high precision optics, and opto-electrical equipment. The company's net profit margin reflects its operational efficiency and profitability trends over time.Hefei I-TEK OptoElectronics, a nimble player in the electronics sector, has demonstrated impressive growth with earnings surging by 306.8% over the past year, outpacing the industry average of 12.5%. The company reported sales of CNY 440.31 million and net income of CNY 64.09 million for the year ending December 2025, reflecting strong operational performance. Despite its volatile share price recently, Hefei I-TEK's debt to equity ratio has significantly improved from 51.1% to just 2.6% over five years, indicating robust financial health and positioning it well for future expansion opportunities in its market segment.Get an in-depth perspective on Hefei I-TEK OptoElectronics' performance by reading our health report here.Explore historical data to track Hefei I-TEK OptoElectronics' performance over time in our Past section.SHSE:688610 Earnings and Revenue Growth as at Apr 2026Allmed Medical ProductsLtd (SZSE:002950)Simply Wall St Value Rating: ★★★★★★Overview: Allmed Medical Products Co., Ltd specializes in the manufacturing and sale of wound care and nursing material products within China, with a market capitalization of CN¥8.39 billion.Operations: The company generates revenue primarily from the sale of wound care and nursing material products.Allmed Medical Products Ltd. paints an intriguing picture with its impressive earnings growth of 100.9% in the past year, outpacing the industry's modest 1.2%. The company appears financially robust, boasting more cash than total debt and reducing its debt-to-equity ratio from 40.3% to 13% over five years. Trading at a discount of 17.9% below fair value estimates, it seems undervalued by market standards. Its high-quality earnings and strong interest coverage ratio of 103.8x EBIT further highlight financial health, while positive free cash flow indicates operational efficiency without immediate liquidity concerns for this promising player in medical equipment manufacturing.Take a closer look at Allmed Medical ProductsLtd's potential here in our health report.Gain insights into Allmed Medical ProductsLtd's past trends and performance with our Past report.SZSE:002950 Debt to Equity as at Apr 2026Jiangsu Jujie Microfiber Technology Group (SZSE:300819)Simply Wall St Value Rating: ★★★★★★Overview: Jiangsu Jujie Microfiber Technology Group Co., Ltd. focuses on the production and sale of microfiber materials and related products, with a market cap of CN¥6.94 billion.Operations: The company's revenue is primarily derived from its Textile and Clothing Business, which generated CN¥565.20 million.Jujie Microfiber, a nimble player in the textile sector, showcases intriguing financial dynamics. Over the past five years, its debt to equity ratio has impressively reduced from 3% to 1.3%, indicating a stronger balance sheet. The company's earnings growth of 1.8% last year outpaced the Luxury industry average of 1.5%. With high-quality past earnings and free cash flow turning positive recently at US$58 million as of December 2024, it seems poised for further stability despite recent share price volatility. Looking ahead, forecasts suggest an annual earnings growth rate of over 36%, hinting at potential value creation opportunities in this niche market segment.Click here and access our complete health analysis report to understand the dynamics of Jiangsu Jujie Microfiber Technology Group.Gain insights into Jiangsu Jujie Microfiber Technology Group's historical performance by reviewing our past performance report.SZSE:300819 Debt to Equity as at Apr 2026Make It HappenUnlock more gems! Our Global Undiscovered Gems With Strong Fundamentals screener has unearthed 3133 more companies for you to explore.Click here to unveil our expertly curated list of 3136 Global Undiscovered Gems With Strong Fundamentals.Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up.Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide.Ready For A Different Approach?Explore high-performing small cap companies that haven't yet garnered significant analyst attention.Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for Free